Hongri Pharmaceutical: Net profit in 2024 was 51.052 million yuan, a year-on-year decrease of 89.92%.

GoldenOctober2024

2025-02-27 12:44:53

Jinshi data news on February 27th, Hongri Pharmaceutical announced that the company’s total operating income in 2024 was 5.783 billion yuan, a year-on-year decrease of 5.34%; the net profit attributable to the shareholders of the listed company was 51.052 million yuan, a year-on-year decrease of 89.92%; the net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 24.0792 million yuan, a year-on-year decrease of 93.59%; the basic earnings per share was 0.02 yuan, a year-on-year decrease of 88.24%; the weighted average return on net assets was 0.59%, a year-on-year decrease of 5.38%.

View Original

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.

Comment

0/400

GateUser-fdebc82e

· 2025-02-27 12:55

interesting post, thanks for it

Reply0